TAK · Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
View on chart this person other insiders at TAK
Insiders & Stakes
| Christophe Pierre Weber President and CEO | ▲ Buy | Grant | 418,803 Shares held | 4/27/2026 | View profile |
| Julie So-Young Kim CEO - Elect | ▼ Sell | Open Market | 391,489 Shares held | 8/10/2026 | View profile |
| Giles Richard Platford President, IBU | ▼ Sell | Open Market | 315,838 Shares held | 8/10/2026 | View profile |
| Teresa Marie Bitetti President, OBU | ▼ Sell | Open Market | 252,010 Shares held | 8/10/2026 | View profile |
| Natalie Anne Marie Furney Global General Counsel | ▼ Sell | Open Market | 204,298 Shares held | 8/10/2026 | View profile |
| Lauren Rusckowski Duprey Chief Transformation Officer | ▼ Sell | Open Market | 191,522 Shares held | 9/14/2026 | View profile |
| Rhonda Janice Pacheco President, U.S. Business Unit | ▼ Sell | Open Market | 182,507 Shares held | 8/10/2026 | View profile |
| Agosti Marcello Pignagnoli Head, Strat. & Port. Dev. | ▼ Sell | Open Market | 176,977 Shares held | 8/10/2026 | View profile |
| Gabriele Ricci Chief Data & Tech. Officer | ▼ Sell | Open Market | 171,654 Shares held | 8/10/2026 | View profile |
| Andrew Stewart Plump President, R&D | ▼ Sell | Open Market | 145,465 Shares held | 9/2/2026 | View profile |
| Awny Samaan Botros Farajallah Chief Medical Officer | ▼ Sell | Open Market | 116,177 Shares held | 8/10/2026 | View profile |
| Ramy Riad Ahmed Ibrahim President, PDT BU | ▼ Sell | Open Market | 102,588 Shares held | 8/10/2026 | View profile |
| Milano Furuta Chief Financial Officer | ▲ Buy | Grant | 70,200 Shares held | 7/1/2026 | View profile |
| Elaine Mary Shannon Pres., Global Supply & Quality | ▼ Sell | Open Market | 67,311 Shares held | 8/11/2026 | View profile |
| Nicola Deidre Petal Greenway Chief Human Resources Officer | ▼ Sell | Open Market | 40,049 Shares held | 8/18/2026 | View profile |
| Jennifer Marie Smoter Chief Comm. & Gov. Officer | ▲ Buy | Grant | 18,808 Shares held | 7/1/2026 | View profile |
| Masami Iijima Director | ▲ Buy | Grant | 14,601 Shares held | 7/1/2026 | View profile |
| John Maraganore Director | ▲ Buy | Grant | 10,400 Shares held | 7/1/2026 | View profile |
| Steven Gillis Director | ▲ Buy | Grant | 10,400 Shares held | 7/1/2026 | View profile |
| Kimberly A. Reed Director | ▲ Buy | Grant | 10,400 Shares held | 7/1/2026 | View profile |
| Miki Tsusaka Director | ▲ Buy | Grant | 8,200 Shares held | 7/1/2026 | View profile |
| Bruce D. Broussard President & CEO | ▲ Buy | Grant | 4,595 Shares held | 7/1/2026 | View profile |
| Asuka Miyabashira President, Japan Pharma B.U. | ▲ Buy | Grant | 4,500 Shares held | 7/1/2026 | View profile |
| Paulus Stoffels Director | ▲ Buy | Grant | 3,800 Shares held | 7/1/2026 | View profile |
| Koichiro Kimura Director | ▲ Buy | Grant | 1,800 Shares held | 7/1/2026 | View profile |
| TAKEDA PHARMACEUTICAL CO LTD 10% Owner | ▼ Sell | Other | 0 Shares held | 9/17/2025 | View profile |
Transaction History
| Lauren Rusckowski Duprey | ▼ Sell | Open Market | 34,535 | $640K | 9/14/2026 |
| Andrew Stewart Plump | ▼ Sell | Open Market | 116,191 | $2.1M | 9/2/2026 |
| Andrew Stewart Plump | ▼ Sell | Open Market | 19,651 | $363K | 8/19/2026 |
| Nicola Deidre Petal Greenway | ▼ Sell | Open Market | 12,980 | $235K | 8/18/2026 |
| Elaine Mary Shannon | ▼ Sell | Open Market | 20,363 | $357K | 8/11/2026 |
| Teresa Marie Bitetti | ▼ Sell | Open Market | 50,012 | $855K | 8/10/2026 |
| Elaine Mary Shannon | ▼ Sell | Open Market | 3,978 | $68K | 8/10/2026 |
| Gabriele Ricci | ▼ Sell | Open Market | 25,088 | $429K | 8/10/2026 |
| Nicola Deidre Petal Greenway | ▼ Sell | Open Market | 6,774 | $116K | 8/10/2026 |
| Julie So-Young Kim | ▼ Sell | Open Market | 89,090 | $1.5M | 8/10/2026 |
| Giles Richard Platford | ▼ Sell | Open Market | 31,083 | $532K | 8/10/2026 |
| Natalie Anne Marie Furney | ▼ Sell | Open Market | 30,868 | $528K | 8/10/2026 |
| Nicola Deidre Petal Greenway | ▼ Sell | Open Market | 975 | $17K | 8/10/2026 |
| Nicola Deidre Petal Greenway | ▼ Sell | Open Market | 33,628 | $589K | 8/10/2026 |
| Awny Samaan Botros Farajallah | ▼ Sell | Open Market | 14,006 | $240K | 8/10/2026 |
| Ramy Riad Ahmed Ibrahim | ▼ Sell | Open Market | 7,277 | $124K | 8/10/2026 |
| Rhonda Janice Pacheco | ▼ Sell | Open Market | 16,901 | $289K | 8/10/2026 |
| Lauren Rusckowski Duprey | ▼ Sell | Open Market | 47,586 | $814K | 8/10/2026 |
| Andrew Stewart Plump | ▼ Sell | Open Market | 165,393 | $2.8M | 8/10/2026 |
| Agosti Marcello Pignagnoli | ▼ Sell | Open Market | 22,957 | $393K | 8/10/2026 |
| Paulus Stoffels | ▲ Buy | Grant | 3,800 | $0 | 7/1/2026 |
| Koichiro Kimura | ▲ Buy | Grant | 1,800 | $0 | 7/1/2026 |
| Miki Tsusaka | ▲ Buy | Grant | 1,800 | $0 | 7/1/2026 |
| Asuka Miyabashira | ▲ Buy | Grant | 1,500 | $0 | 7/1/2026 |
| Milano Furuta | ▲ Buy | Grant | 12,300 | $0 | 7/1/2026 |
| Giles Richard Platford | ▲ Buy | Grant | 49,558 | $0 | 7/1/2026 |
| Jennifer Marie Smoter | ▲ Buy | Grant | 18,808 | $0 | 7/1/2026 |
| Ramy Riad Ahmed Ibrahim | ▲ Buy | Grant | 25,078 | $0 | 7/1/2026 |
| Nicola Deidre Petal Greenway | ▲ Buy | Grant | 22,570 | $0 | 7/1/2026 |
| Rhonda Janice Pacheco | ▲ Buy | Grant | 50,156 | $0 | 7/1/2026 |
| Agosti Marcello Pignagnoli | ▲ Buy | Grant | 27,586 | $0 | 7/1/2026 |
| Gabriele Ricci | ▲ Buy | Grant | 37,616 | $0 | 7/1/2026 |
| Elaine Mary Shannon | ▲ Buy | Grant | 30,094 | $0 | 7/1/2026 |
| Lauren Rusckowski Duprey | ▲ Buy | Grant | 45,140 | $0 | 7/1/2026 |
| Teresa Marie Bitetti | ▲ Buy | Grant | 43,886 | $0 | 7/1/2026 |
| Julie So-Young Kim | ▲ Buy | Grant | 50,434 | $0 | 7/1/2026 |
| Julie So-Young Kim | ▲ Buy | Grant | 22,800 | $0 | 7/1/2026 |
| Andrew Stewart Plump | ▲ Buy | Grant | 125,390 | $0 | 7/1/2026 |
| Steven Gillis | ▲ Buy | Grant | 3,800 | $0 | 7/1/2026 |
| John Maraganore | ▲ Buy | Grant | 3,800 | $0 | 7/1/2026 |
| Kimberly A. Reed | ▲ Buy | Grant | 3,800 | $0 | 7/1/2026 |
| Masami Iijima | ▲ Buy | Grant | 1,800 | $0 | 7/1/2026 |
| Bruce D. Broussard | ▲ Buy | Grant | 3,800 | $0 | 7/1/2026 |
| Awny Samaan Botros Farajallah | ▲ Buy | Grant | 17,554 | $0 | 7/1/2026 |
| Natalie Anne Marie Furney | ▲ Buy | Grant | 43,886 | $0 | 7/1/2026 |
| Christophe Pierre Weber | ▲ Buy | Grant | 78,900 | $0 | 4/27/2026 |
| Christophe Pierre Weber | ▲ Buy | Grant | 165,370 | $0 | 4/27/2026 |
| Teresa Marie Bitetti | ▲ Buy | Grant | 64,988 | $0 | 4/27/2026 |
| Gabriele Ricci | ▲ Buy | Grant | 34,994 | $0 | 4/27/2026 |
| Andrew Stewart Plump | ▲ Buy | Grant | 212,470 | $0 | 4/27/2026 |
| Milano Furuta | ▲ Buy | Grant | 7,800 | $0 | 4/27/2026 |
| Lauren Rusckowski Duprey | ▲ Buy | Grant | 59,990 | $0 | 4/27/2026 |
| Julie So-Young Kim | ▲ Buy | Grant | 105,416 | $0 | 4/27/2026 |
| Giles Richard Platford | ▲ Buy | Grant | 72,124 | $0 | 4/27/2026 |
| Agosti Marcello Pignagnoli | ▲ Buy | Grant | 27,740 | $0 | 4/27/2026 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Other | 6,724,000 | $13.1M | 9/17/2025 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Open Market | 3,703,703 | $30.0M | 1/24/2024 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Other | 5,883,500 | $0 | 11/30/2022 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Other | 7,359,304 | $0 | 3/14/2022 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Open Market | 18 | $342 | 3/14/2022 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Open Market | 110,338 | $2.0M | 12/8/2021 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Open Market | 58,190 | $1.1M | 12/7/2021 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Open Market | 128,745 | $2.4M | 12/7/2021 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Open Market | 97,692 | $1.8M | 12/6/2021 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Open Market | 12,517 | $231K | 12/3/2021 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Other | 57,224 | $0 | 11/24/2021 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Other | 228,696 | $0 | 11/4/2021 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Open Market | 1 | $19 | 11/4/2021 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Open Market | 1,000,000 | $20.9M | 11/4/2021 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Other | 1,475,121 | — | 10/26/2021 |
| TAKEDA PHARMACEUTICAL CO LTD | ▼ Sell | Other | 1,615,427 | — | 10/12/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Takeda Launches Narcolepsy Drug in Asia, Presents PID Study Data
Takeda has launched its new narcolepsy treatment, ORZEYFUL, in Japan and China, marking the first availability of this orexin agonist for patients with narcolepsy type 1. The company also presented Phase 2/3 clinical data for its investigational drug TAK-881 for primary immunodeficiency disease at a recent medical conference. These pipeline advancements represent key milestones in Takeda's therapeutic portfolio expansion.
Takeda Launches Narcolepsy Drug in Asia, Presents PID Study Data. Takeda has launched its new narcolepsy treatment, ORZEYFUL, in Japan and China, marking the first availability of this orexin agonist for patients with narcolepsy type 1. The company also presented Phase 2/3 clinical data for its investigational drug TAK-881 for primary immunodeficiency disease at a recent medical conference. These pipeline advancements represent key milestones in Takeda's therapeutic portfolio expansion.